Biology

Trial By Error: A Commercial Deal for King’s College London’s IBS-CBT Digital Program




By David Tuller, DrPH On January 10th, the following information was announced in a press release: Mahana Therapeutics, a digital therapeutics company reimagining the treatment of chronic diseases, today announced that the Company has entered into a licensing and collaboration agreement with King’s College London, a leading research university and one of the oldest and […]

Source link






Related posts

Domestication of High-Copy Transposons Underlays the Wheat Small RNA Response to an Obligate Pathogen

Newsemia

Anabolic SIRT4 Exerts Retrograde Control over TORC1 Signaling by Glutamine Sparing in the Mitochondria [Research Article]

Newsemia

Senior Research Technician in the Panfilio Lab, University of Warwick, UK

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy